ID   OX-CO-1
AC   CVCL_B451
SY   OXCO-1; OXCO1
DR   GEO; GSM1448134
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54937176
RX   PubMed=17312135;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
RX   PubMed=17312135; DOI=10.4049/jimmunol.178.5.2908;
RA   Ling K.-L., Dulphy N., Bahl P., Salio M., Maskell K., Piris J.,
RA   Warren B.F., George B.D., Mortensen N.J., Cerundolo V.;
RT   "Modulation of CD103 expression on human colon carcinoma-specific
RT   CTL.";
RL   J. Immunol. 178:2908-2915(2007).
//
RX   PubMed=18258742; DOI=10.1073/pnas.0712176105; PMCID=PMC2268141;
RA   Emaduddin M., Bicknell D.C., Bodmer W.F., Feller S.M.;
RT   "Cell growth, global phosphotyrosine elevation, and c-Met
RT   phosphorylation through Src family kinases in colorectal cancer
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2358-2362(2008).
//
RX   PubMed=20606684; DOI=10.1038/sj.bjc.6605780; PMCID=PMC2920028;
RA   Bracht K., Nicholls A.M., Liu Y., Bodmer W.F.;
RT   "5-fluorouracil response in a large panel of colorectal cancer cell
RT   lines is associated with mismatch repair deficiency.";
RL   Br. J. Cancer 103:340-346(2010).
//
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).
//
RX   PubMed=29101300; DOI=10.15252/msb.20177701; PMCID=PMC5731344;
RA   Frejno M., Zenezini Chiozzi R., Wilhelm M., Koch H., Zheng R.-S.,
RA   Klaeger S., Ruprecht B., Meng C., Kramer K., Jarzab A., Heinzlmeir S.,
RA   Johnstone E., Domingo E., Kerr D.J., Jesinghaus M., Slotta-Huspenina J.,
RA   Weichert W., Knapp S., Feller S.M., Kuster B.;
RT   "Pharmacoproteomic characterisation of human colon and rectal
RT   cancer.";
RL   Mol. Syst. Biol. 13:951-951(2017).
//